Vancomycin-resistant gut commensal Clostridium innocuum emerges as a pathobiont through synergy with toxigenic

Chia-Jung Kuo1, Tsui-Shan Hsu2, Chin-Ming Hsu2

  • 1School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan; Chang Gung Microbiota Therapy Center, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Insights

Clostridium innocuum worsens outcomes in Clostridioides difficile infection (CDI) by enhancing cell damage and barrier disruption. Its vancomycin resistance allows it to thrive during treatment, highlighting its role as a pathobiont.

Area of Science:

  • Microbiology
  • Pathogenesis
  • Host-pathogen interactions

Background:

  • Clostridium innocuum is increasingly found in patients with Clostridioides difficile infection (CDI).
  • Its pathogenic role and cytotoxic mechanisms, especially in conjunction with C. difficile, are not well understood.
  • C. innocuum's intrinsic vancomycin resistance contributes to its persistence during CDI treatment.

Purpose of the Study:

  • To investigate the synergistic interactions between C. difficile and C. innocuum in human intestinal epithelial cells.
  • To elucidate the mechanisms by which C. innocuum influences host cell damage and barrier function during co-infection.

Main Methods:

  • Co-infection models using toxigenic C. difficile and C. innocuum in human intestinal epithelial cells.
  • Assessment of cytotoxicity, epithelial barrier integrity, and host cell apoptosis pathways (p53, BAX/BCL-2, PARP1).

Main Results:

  • C. innocuum alone showed minimal cytotoxicity, but significantly increased cell death and barrier disruption when co-infecting with C. difficile.
  • C. difficile pre-infection facilitated C. innocuum translocation, indicating toxin-mediated barrier damage aids colonization.
  • Co-infection activated p53 signaling and modulated the BAX/BCL-2 ratio, promoting apoptosis via PARP1.

Conclusions:

  • Toxigenic C. difficile facilitates C. innocuum invasion and exacerbates host cell damage through synergistic interactions.
  • C. innocuum acts as a clinically relevant pathobiont in CDI, particularly under vancomycin treatment.
  • Findings underscore the need for improved diagnostics and targeted therapeutic strategies for managing CDI co-infections.

Related Concept Videos

Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
154
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.7K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
603
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
92
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
222
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
108